Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Imipramine HCl 150 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the medication over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. These capsules are used to treat conditions such as depression, anxiety, obsessive-compulsive disorder, panic disorder, and enuresis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Imipramine HCl 150 mg Slow Release Capsules are a specialized medication designed to treat a range of mental health conditions, including depression, anxiety, and panic disorder. This unique formulation incorporates Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, imipramine hydrochloride, over an extended period. This slow-release mechanism offers consistent therapeutic effects, reduces the frequency of dosing, and enhances patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
This formulation is specifically designed to manage both acute and chronic episodes of depression, anxiety, and panic disorder. The slow and steady release of the medication helps to minimize the risk of side effects and ensures that the patient receives a consistent dose of the medication. However, it is crucial to note that Imipramine HCl 150 mg Slow Release Capsules should not be used in conjunction with other antidepressants or antipsychotics without medical advice.
Imipramine HCl 150 mg Slow Release Capsules are a appropriate treatment option for those battling mental health conditions. However, it is essential that this medication is taken as prescribed by a healthcare provider. Any changes in dosage or frequency should be discussed with a healthcare professional. Patients should also be aware of potential side effects, which may include dry mouth, constipation, dizziness, and drowsiness.
At Bayview Pharmacy, we are committed to providing high-quality compounding services, including the provision of Imipramine HCl 150 mg Slow Release Capsules. We encourage anyone with questions about this formulation or any other services we offer to reach out to us. Our team is here to provide the support and information you need to make informed decisions about your health.
Imipramine HCl 150 mg Slow Release Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
It's important to note that Imipramine HCl 150 mg Slow Release Capsules may interact with other medications. These include monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, antipsychotics, anticholinergics, antihistamines, and other drugs that affect serotonin levels. Therefore, patients should inform their healthcare provider of all medications they are currently taking. This includes over-the-counter medications, vitamins, and herbal supplements.
Patients should also be aware of potential drug-drug interactions, particularly those that may increase the risk of serotonin syndrome. Signs and symptoms of serotonin syndrome to watch out for include agitation, confusion, sweating, fever, shivering, tremor, and muscle rigidity. Regular monitoring for changes in blood pressure, heart rate, and other vital signs is also recommended.
Patients are advised to avoid alcohol while taking Imipramine HCl 150 mg Slow Release Capsules. If you have any questions or concerns about this medication, please do not hesitate to reach out to your healthcare provider.
Imipramine HCl 150 mg Slow Release Capsules are a potent medication primarily used in the treatment of depression, panic disorder, and enuresis (bedwetting). This medication functions by augmenting the quantity of specific natural substances in the brain, which are essential for maintaining mental equilibrium.
These capsules are uniquely formulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication or active ingredient over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and enhances patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
Imipramine HCl 150 mg Slow Release Capsules should be administered orally, typically once daily, and can be taken with or without food. It is crucial to adhere to the prescribed dosage by your healthcare provider. Avoid taking more or less of the medication or taking it more frequently than recommended by your doctor.
It may take several weeks before the full therapeutic effects of Imipramine HCl 150 mg Slow Release Capsules become noticeable. Do not discontinue this medication without first consulting your doctor.
If you are pregnant, planning to conceive, or breastfeeding, it is vital to inform your doctor. It is equally important to disclose all other medications you are currently taking, including over-the-counter medications, vitamins, and herbal supplements, to your doctor.
While taking Imipramine HCl 150 mg Slow Release Capsules, if you experience any side effects such as dry mouth, drowsiness, dizziness, constipation, blurred vision, or difficulty urinating, contact your healthcare provider immediately.
If you have any queries or concerns about Imipramine HCl 150 mg Slow Release Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your medication needs.
Imipramine HCl 150 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time, offering sustained therapeutic effects.
The slow release formulation offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
Methocel E4M works by controlling the release of the active ingredient in the medication. It gradually releases the medication over an extended period of time, providing a sustained therapeutic effect.
The frequency of dosing will depend on your doctor's prescription. However, the slow release formulation is designed to reduce the frequency of dosing, making it more convenient for patients.
A controlled and prolonged release profile ensures that the medication is gradually released over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance.
No, the capsules should not be broken or chewed. Doing so can interfere with the controlled-release mechanism of the medication, potentially leading to a sudden release of the active ingredient.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double up on doses.
If you experience any side effects, contact your healthcare provider immediately. They can provide guidance on how to manage these side effects and determine whether you should continue taking the medication.
Before starting any new medication, you should always inform your healthcare provider about all the medications you are currently taking. They can assess whether there may be any potential interactions between the medications.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
